-
EP2007814
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2007814
| EP2007814 - SINGLE DOMAIN VHH ANTIBODIES AGAINST VON WILLEBRAND FACTOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.07.2012 Database last updated on 03.09.2024 | Most recent event Tooltip | 20.07.2012 | Application deemed to be withdrawn | published on 22.08.2012 [2012/34] | Applicant(s) | For all designated states Ablynx N.V. Technologiepark 21 9052 Ghent-Zwijnaarde / BE | [2011/42] |
| Former [2009/01] | For all designated states Ablynx N.V. Technologiepark 4 9052 Zwijnaarde / BE | Inventor(s) | 01 /
SILENCE, Karen Jean-Tombeurstraat 21 B-3090 Overijse / BE | [2009/01] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
| Former [2009/01] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | Application number, filing date | 06776035.5 | 19.05.2006 | [2009/01] | WO2006EP04773 | Priority number, date | US20050683474P | 20.05.2005 Original published format: US 683474 P | [2009/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006122825 | Date: | 23.11.2006 | Language: | EN | [2006/47] | Type: | A2 Application without search report | No.: | EP2007814 | Date: | 31.12.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.11.2006 takes the place of the publication of the European patent application. | [2009/01] | Search report(s) | International search report - published on: | EP | 04.10.2007 | Classification | IPC: | C07K16/36, A61K38/36 | [2009/01] | CPC: |
C07K16/36 (EP,KR,NO,US);
A61K38/36 (EP,KR,NO,US);
A61P41/00 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P9/10 (EP);
A61P9/14 (EP);
C07K14/47 (NO);
A61K2039/505 (EP,US);
B82Y5/00 (KR);
C07K2317/22 (EP,US);
C07K2317/24 (EP,US);
C07K2317/569 (EP,US);
C07K2317/76 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2009/01] | Title | German: | EINZELDOMÄNEN-VHH-ANTIKÖRPER GEGEN DEN VON-WILLEBRAND-FAKTOR | [2009/01] | English: | SINGLE DOMAIN VHH ANTIBODIES AGAINST VON WILLEBRAND FACTOR | [2009/01] | French: | "NANOBODIES " (NANOCORPS) PERFECTIONNES POUR TRAITER DES TROUBLES MEDIES PAR UNE AGREGATION | [2009/01] | Entry into regional phase | 27.11.2007 | National basic fee paid | 27.11.2007 | Designation fee(s) paid | 27.11.2007 | Examination fee paid | Examination procedure | 27.11.2007 | Examination requested [2009/01] | 03.03.2008 | Amendment by applicant (claims and/or description) | 21.07.2011 | Despatch of a communication from the examining division (Time limit: M06) | 01.02.2012 | Application deemed to be withdrawn, date of legal effect [2012/34] | 08.03.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/34] | Divisional application(s) | EP12151893.0 / EP2444424 | EP17175833.7 / EP3243839 | EP18186517.1 / EP3415535 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.07.2011 | Fees paid | Renewal fee | 26.03.2008 | Renewal fee patent year 03 | 26.05.2009 | Renewal fee patent year 04 | 24.03.2010 | Renewal fee patent year 05 | 24.05.2011 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.05.2012 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0024781 (BRIGHAM & WOMENS HOSPITAL [US]) [X] 1-78 * the whole document *; | [X]WO2004062551 (ABLYNX NV [BE], et al) [X] 1-78 * the whole document *; | [PX] - HULSTEIN JANINE J J ET AL, "A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS 13 deficiency and von Willebrand disease type 2B", BLOOD, (200511), vol. 106, no. 9, ISSN 0006-4971, pages 3035 - 3042, XP002434260 [PX] 1-78 * the whole document * DOI: http://dx.doi.org/10.1182/blood-2005-03-1153 | [PX] - SILENCE KAREN ET AL, "ALX-0081 Nanobody (TM), an engineered bivalent anti-thrombotic drug candidate with improved efficacy and safety as compared to the marketed drugs.", BLOOD, & 48TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ORLANDO, FL, USA; DECEMBER 09 -12, 2006, (200611), vol. 108, no. 11, Part 1, ISSN 0006-4971, page 269A, XP009085105 [PX] 1-78 * abstract * |